Predictors of progression in patients with AD and Lewy bodies

Neurology

Volumn 54, Issue 9, 2000, Pages 1774-1779

  Lopez, O L ^a   Wisniewski, S ^b   Hamilton, R L ^b   Becker, J T ^b   Kaufer, D I ^b   DeKosky, S T ^b  

^a Neuropsychological Research Program   (United States)

^b NONE

Author keywords

AD; Lewy bodies; Predictors of progression

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; DELUSION; DIAGNOSTIC VALUE; FEMALE; HALLUCINATION; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0034624940     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.9.1774     Document Type: Article

References (41)

1. Gibb WR, Mountjoy CQ, Mann DM, Lees AJ. A pathological study of the association between Lewy body disease and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1989;52: 701-708.
2. Hansen LA, Samuel W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 1997; 48:126-132.
3. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990;40:1-8.
4. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 1994;35:81-88.
5. Brown DF, Risser RC, Bigio EH, et al. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging. J Neuropathol Exp Neurol 1998;57:955-960.
6. Heyman A, Fillenbaum GG, Gearing M, et al. Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease. Neurology 1999;52:1839-1844.
7. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report on the Consortium on DLB international workshop. Neurology 1996;47:1113-1124.
8. Klatka LA, Louis ED, Schiffer RB. Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 1996;47:1148-1152.
9. Ferman TJ, Boeve BF, Smith GE, et al. REM sleep behavior disorder and dementia: cognitive differences when compared with AD. Neurology 1999;52:951-957.
10. Briel RC, McKeith IG, Barker WA, et al. EEG findings in dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999;66:401-403.
11. Del-Ser T, Muñoz DG, Hachinski V. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology 1996;46:682-686.
12. Lopez OL, Hamilton RL, Becker JT, Wisniewski S, Kaufer DI, DeKosky ST. Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology 2000;54:1780-1787.
13. Weiner MF, Risser RC, Cullum M, et al. Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry 1996;153:1269-1273.
14. Papka M, Rubio A, Schiffer RB, Cox C. Lewy body disease: can we diagnose it? J Neuropsychiatr Clin Neurosci 1998;10: 405-412.
15. Armstrong TP, Hansen LA, Salmon DP, et al. Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer's disease. Neurology 1991;41:1178-1180.
16. Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST. Extrapyramidal signs in patients with probable Alzheimer's disease. Arch Neurol 1997;54:969-975.
17. Lopez OL, Becker JT, Brenner RP, Rosen J, Bajulaiye OI, Reynolds III CF. Alzheimer's disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology 1991;41:906-912.
18. Stern Y, Albert M, Brandt J, et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology 1994;44:2300-2307.
19. Lopez OL, Hamilton R, Becker JT, Wisniewski SR, Kaufer DI, DeKosky ST. Clinical features and predictors of progression in patients with Alzheimer's disease and with the Lewy body variant of Alzheimer's disease. Neurology 1998;50(suppl 4): A215. Abstract.
20. Lopez OL, Swihart AA, Becker JT, et al. Reliability of NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease. Neurology 1990;40:1517-1522.
21. Lopez OL, Larumbe MR, Becker JT, et al. Reliability of NINDS-AIREN criteria for vascular dementia. Neurology 1994;44:1240-1245.
22. Mezzich JE, Dow JT, Cottman GA. Developing an information system for a comprehensive psychiatric institute, I. Principles, design, and organization. Behav Res Methods Instrument 1981;13:459-463.
23. American Psychiatric Association. DSM-III-R. Diagnostic and statistical manual of mental disorders, third edition, revised. Washington, DC: American Psychiatric Association, 1987.
24. Tariot PN, Mack JL, Patterson MB, et al. The behavior rating scale for dementia of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995;152:1349-1357.
25. American Psychiatric Association. DSM-IV. Diagnostic and statistical manual of mental disorders, fourth edition. Washington, DC: American Psychiatric Association, 1994.
26. American Psychiatric Association. DSM-III. Diagnostic and statistical manual of mental disorders, third edition. Washington DC: American Psychiatric Association, 1980.
27. Lopez OL, Gonzalez MP, Becker JT, Reynolds CF, Sudilovsky A, DeKosky ST. Symptoms of depression and psychosis in Alzheimer's disease and frontotemporal dementia. Neuropsychiatr Neuropsychol Behav Neurol 1996;9:154-161.
28. Becker JT, Boller F, Lopez OL, Saxton J, McGonigle K. The natural history of Alzheimer's disease: description of study cohort and accuracy of diagnosis. Arch Neurol 1994;51:585-594.
29. Hoehn M, Yahr M. Parkinsonism. Onset, progression, and mortality. Neurology 1967;17:427-442.
30. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991;41:479-486.
31. National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease: consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:51-52.
32. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and senile changes in the cerebral white matter of elderly subjects. Br J Psychiatr 1968; 114:797-811.
33. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method grading the cognitive state of patients for the clinician. Psychiatr Res 1975;12:189-198.
34. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karuso TB, eds. Geriatric psychiatry. New York: Grune & Stratton, 1976.
35. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
36. Hachinski VC, Iliff LD, Zihka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
37. Cercy SP, Bylsma FW. Lewy bodies and progressive dementia: a critical review and meta-analysis. J Int Neuropsychol Soc 1997;3:179-194.
38. Chen J-Y, Stern Y, Sano M, Mayeux R. Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol 1991;48:1141-1143.
39. Morris JC, Drazner M, Fulling K, Grant E, Goldring J. Clinical and pathological aspects of parkinsonism in Alzheimer's disease: a role for extranigral factors? Arch Neurol 1989;46: 651-657.
40. Liu Y, Stern Y, Chun MR, Jacob DM, Yau P, Goldman JE. Pathological correlates of extrapyramidal signs in Alzheimer's disease. Ann Neurol 1997;41:368-374.
41. McKeith I, Perry EK, Perry RH, et al. Report of the second dementia with Lewy body international workshop. Diagnosis and treatment. Neurology 1999;53:902-905.